nodes	percent_of_prediction	percent_of_DWPC	metapath
Tizanidine—NISCH—Podofilox—Etoposide—urinary bladder cancer	0.0175	1	CbGdCrCtD
Tizanidine—CYP1A2—urine—urinary bladder cancer	0.0127	0.141	CbGeAlD
Tizanidine—NISCH—prostate gland—urinary bladder cancer	0.0115	0.128	CbGeAlD
Tizanidine—NISCH—smooth muscle tissue—urinary bladder cancer	0.00815	0.0907	CbGeAlD
Tizanidine—NISCH—urethra—urinary bladder cancer	0.00771	0.0857	CbGeAlD
Tizanidine—NISCH—vagina—urinary bladder cancer	0.00569	0.0632	CbGeAlD
Tizanidine—ADRA2C—prostate gland—urinary bladder cancer	0.00526	0.0585	CbGeAlD
Tizanidine—ADRA2C—seminal vesicle—urinary bladder cancer	0.00445	0.0495	CbGeAlD
Tizanidine—ADRA2A—prostate gland—urinary bladder cancer	0.0042	0.0467	CbGeAlD
Tizanidine—NISCH—lymph node—urinary bladder cancer	0.00368	0.0409	CbGeAlD
Tizanidine—ADRA2C—renal system—urinary bladder cancer	0.00359	0.0399	CbGeAlD
Tizanidine—ADRA2A—seminal vesicle—urinary bladder cancer	0.00355	0.0395	CbGeAlD
Tizanidine—ADRA2C—urethra—urinary bladder cancer	0.00352	0.0392	CbGeAlD
Tizanidine—CYP1A2—renal system—urinary bladder cancer	0.00311	0.0346	CbGeAlD
Tizanidine—ADRA2A—urethra—urinary bladder cancer	0.00281	0.0312	CbGeAlD
Tizanidine—ADRA2C—vagina—urinary bladder cancer	0.0026	0.0289	CbGeAlD
Tizanidine—ADRA2A—female reproductive system—urinary bladder cancer	0.00229	0.0255	CbGeAlD
Tizanidine—ADRA2A—vagina—urinary bladder cancer	0.00207	0.023	CbGeAlD
Tizanidine—ADRA2C—lymph node—urinary bladder cancer	0.00168	0.0187	CbGeAlD
Tizanidine—ADRA2A—lymph node—urinary bladder cancer	0.00134	0.0149	CbGeAlD
Tizanidine—Hepatitis—Methotrexate—urinary bladder cancer	0.000559	0.000626	CcSEcCtD
Tizanidine—Haemorrhage—Methotrexate—urinary bladder cancer	0.000559	0.000626	CcSEcCtD
Tizanidine—Sweating—Epirubicin—urinary bladder cancer	0.000558	0.000625	CcSEcCtD
Tizanidine—Pollakiuria—Doxorubicin—urinary bladder cancer	0.000558	0.000625	CcSEcCtD
Tizanidine—Asthenia—Gemcitabine—urinary bladder cancer	0.000557	0.000624	CcSEcCtD
Tizanidine—Haematuria—Epirubicin—urinary bladder cancer	0.000555	0.000622	CcSEcCtD
Tizanidine—Pharyngitis—Methotrexate—urinary bladder cancer	0.000554	0.000621	CcSEcCtD
Tizanidine—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.000552	0.000618	CcSEcCtD
Tizanidine—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000551	0.000617	CcSEcCtD
Tizanidine—Pruritus—Gemcitabine—urinary bladder cancer	0.000549	0.000615	CcSEcCtD
Tizanidine—Nausea—Thiotepa—urinary bladder cancer	0.000548	0.000614	CcSEcCtD
Tizanidine—Urethral disorder—Methotrexate—urinary bladder cancer	0.000547	0.000613	CcSEcCtD
Tizanidine—Weight decreased—Doxorubicin—urinary bladder cancer	0.000547	0.000612	CcSEcCtD
Tizanidine—Sinusitis—Epirubicin—urinary bladder cancer	0.000546	0.000612	CcSEcCtD
Tizanidine—Feeling abnormal—Etoposide—urinary bladder cancer	0.000546	0.000612	CcSEcCtD
Tizanidine—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.000545	0.000611	CcSEcCtD
Tizanidine—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000543	0.000609	CcSEcCtD
Tizanidine—Pneumonia—Doxorubicin—urinary bladder cancer	0.000542	0.000607	CcSEcCtD
Tizanidine—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000542	0.000607	CcSEcCtD
Tizanidine—Pruritus—Fluorouracil—urinary bladder cancer	0.00054	0.000605	CcSEcCtD
Tizanidine—Drowsiness—Doxorubicin—urinary bladder cancer	0.000539	0.000604	CcSEcCtD
Tizanidine—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000534	0.000598	CcSEcCtD
Tizanidine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000533	0.000597	CcSEcCtD
Tizanidine—Bradycardia—Epirubicin—urinary bladder cancer	0.000532	0.000596	CcSEcCtD
Tizanidine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000531	0.000595	CcSEcCtD
Tizanidine—Renal failure—Doxorubicin—urinary bladder cancer	0.00053	0.000593	CcSEcCtD
Tizanidine—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000528	0.000592	CcSEcCtD
Tizanidine—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000528	0.000592	CcSEcCtD
Tizanidine—Urticaria—Etoposide—urinary bladder cancer	0.000526	0.00059	CcSEcCtD
Tizanidine—Haemoglobin—Epirubicin—urinary bladder cancer	0.000525	0.000589	CcSEcCtD
Tizanidine—Jaundice—Doxorubicin—urinary bladder cancer	0.000525	0.000588	CcSEcCtD
Tizanidine—Rhinitis—Epirubicin—urinary bladder cancer	0.000524	0.000587	CcSEcCtD
Tizanidine—Abdominal pain—Etoposide—urinary bladder cancer	0.000524	0.000587	CcSEcCtD
Tizanidine—Body temperature increased—Etoposide—urinary bladder cancer	0.000524	0.000587	CcSEcCtD
Tizanidine—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000524	0.000587	CcSEcCtD
Tizanidine—Haemorrhage—Epirubicin—urinary bladder cancer	0.000523	0.000586	CcSEcCtD
Tizanidine—Hepatitis—Epirubicin—urinary bladder cancer	0.000523	0.000586	CcSEcCtD
Tizanidine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000522	0.000585	CcSEcCtD
Tizanidine—Tinnitus—Methotrexate—urinary bladder cancer	0.000521	0.000583	CcSEcCtD
Tizanidine—Asthenia—Cisplatin—urinary bladder cancer	0.000519	0.000581	CcSEcCtD
Tizanidine—Pharyngitis—Epirubicin—urinary bladder cancer	0.000519	0.000581	CcSEcCtD
Tizanidine—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000518	0.000581	CcSEcCtD
Tizanidine—Sweating—Doxorubicin—urinary bladder cancer	0.000516	0.000579	CcSEcCtD
Tizanidine—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000516	0.000578	CcSEcCtD
Tizanidine—Haematuria—Doxorubicin—urinary bladder cancer	0.000514	0.000575	CcSEcCtD
Tizanidine—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000514	0.000575	CcSEcCtD
Tizanidine—Urethral disorder—Epirubicin—urinary bladder cancer	0.000512	0.000574	CcSEcCtD
Tizanidine—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000509	0.000571	CcSEcCtD
Tizanidine—Angiopathy—Methotrexate—urinary bladder cancer	0.000507	0.000568	CcSEcCtD
Tizanidine—Sinusitis—Doxorubicin—urinary bladder cancer	0.000505	0.000566	CcSEcCtD
Tizanidine—Immune system disorder—Methotrexate—urinary bladder cancer	0.000504	0.000565	CcSEcCtD
Tizanidine—Dizziness—Fluorouracil—urinary bladder cancer	0.000504	0.000565	CcSEcCtD
Tizanidine—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000503	0.000564	CcSEcCtD
Tizanidine—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000503	0.000563	CcSEcCtD
Tizanidine—Diarrhoea—Cisplatin—urinary bladder cancer	0.000495	0.000554	CcSEcCtD
Tizanidine—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000494	0.000554	CcSEcCtD
Tizanidine—Alopecia—Methotrexate—urinary bladder cancer	0.000494	0.000553	CcSEcCtD
Tizanidine—Vomiting—Gemcitabine—urinary bladder cancer	0.000493	0.000553	CcSEcCtD
Tizanidine—Bradycardia—Doxorubicin—urinary bladder cancer	0.000492	0.000552	CcSEcCtD
Tizanidine—Mental disorder—Methotrexate—urinary bladder cancer	0.000489	0.000548	CcSEcCtD
Tizanidine—Rash—Gemcitabine—urinary bladder cancer	0.000489	0.000548	CcSEcCtD
Tizanidine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000489	0.000547	CcSEcCtD
Tizanidine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000488	0.000547	CcSEcCtD
Tizanidine—Tinnitus—Epirubicin—urinary bladder cancer	0.000487	0.000546	CcSEcCtD
Tizanidine—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000486	0.000545	CcSEcCtD
Tizanidine—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000485	0.000543	CcSEcCtD
Tizanidine—Vomiting—Fluorouracil—urinary bladder cancer	0.000485	0.000543	CcSEcCtD
Tizanidine—Rhinitis—Doxorubicin—urinary bladder cancer	0.000485	0.000543	CcSEcCtD
Tizanidine—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000484	0.000542	CcSEcCtD
Tizanidine—Hepatitis—Doxorubicin—urinary bladder cancer	0.000484	0.000542	CcSEcCtD
Tizanidine—Rash—Fluorouracil—urinary bladder cancer	0.000481	0.000539	CcSEcCtD
Tizanidine—Dermatitis—Fluorouracil—urinary bladder cancer	0.00048	0.000538	CcSEcCtD
Tizanidine—Pharyngitis—Doxorubicin—urinary bladder cancer	0.00048	0.000538	CcSEcCtD
Tizanidine—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000478	0.000535	CcSEcCtD
Tizanidine—Asthenia—Etoposide—urinary bladder cancer	0.000475	0.000532	CcSEcCtD
Tizanidine—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000475	0.000532	CcSEcCtD
Tizanidine—Angiopathy—Epirubicin—urinary bladder cancer	0.000474	0.000531	CcSEcCtD
Tizanidine—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000474	0.000531	CcSEcCtD
Tizanidine—Immune system disorder—Epirubicin—urinary bladder cancer	0.000472	0.000529	CcSEcCtD
Tizanidine—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000471	0.000528	CcSEcCtD
Tizanidine—Back pain—Methotrexate—urinary bladder cancer	0.00047	0.000527	CcSEcCtD
Tizanidine—Pruritus—Etoposide—urinary bladder cancer	0.000469	0.000525	CcSEcCtD
Tizanidine—Arrhythmia—Epirubicin—urinary bladder cancer	0.000467	0.000523	CcSEcCtD
Tizanidine—Alopecia—Epirubicin—urinary bladder cancer	0.000462	0.000517	CcSEcCtD
Tizanidine—Nausea—Gemcitabine—urinary bladder cancer	0.000461	0.000516	CcSEcCtD
Tizanidine—Vomiting—Cisplatin—urinary bladder cancer	0.00046	0.000515	CcSEcCtD
Tizanidine—Vision blurred—Methotrexate—urinary bladder cancer	0.000458	0.000513	CcSEcCtD
Tizanidine—Mental disorder—Epirubicin—urinary bladder cancer	0.000458	0.000513	CcSEcCtD
Tizanidine—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000457	0.000512	CcSEcCtD
Tizanidine—Rash—Cisplatin—urinary bladder cancer	0.000456	0.000511	CcSEcCtD
Tizanidine—Dermatitis—Cisplatin—urinary bladder cancer	0.000455	0.00051	CcSEcCtD
Tizanidine—Diarrhoea—Etoposide—urinary bladder cancer	0.000453	0.000508	CcSEcCtD
Tizanidine—Nausea—Fluorouracil—urinary bladder cancer	0.000453	0.000508	CcSEcCtD
Tizanidine—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000451	0.000505	CcSEcCtD
Tizanidine—Tinnitus—Doxorubicin—urinary bladder cancer	0.000451	0.000505	CcSEcCtD
Tizanidine—Anaemia—Methotrexate—urinary bladder cancer	0.000449	0.000503	CcSEcCtD
Tizanidine—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000449	0.000503	CcSEcCtD
Tizanidine—Flatulence—Epirubicin—urinary bladder cancer	0.000448	0.000502	CcSEcCtD
Tizanidine—Tension—Epirubicin—urinary bladder cancer	0.000446	0.0005	CcSEcCtD
Tizanidine—Nervousness—Epirubicin—urinary bladder cancer	0.000442	0.000495	CcSEcCtD
Tizanidine—Back pain—Epirubicin—urinary bladder cancer	0.00044	0.000493	CcSEcCtD
Tizanidine—Angiopathy—Doxorubicin—urinary bladder cancer	0.000439	0.000492	CcSEcCtD
Tizanidine—Malaise—Methotrexate—urinary bladder cancer	0.000438	0.000491	CcSEcCtD
Tizanidine—Dizziness—Etoposide—urinary bladder cancer	0.000438	0.000491	CcSEcCtD
Tizanidine—Muscle spasms—Epirubicin—urinary bladder cancer	0.000437	0.00049	CcSEcCtD
Tizanidine—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000437	0.000489	CcSEcCtD
Tizanidine—Vertigo—Methotrexate—urinary bladder cancer	0.000437	0.000489	CcSEcCtD
Tizanidine—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000436	0.000488	CcSEcCtD
Tizanidine—Leukopenia—Methotrexate—urinary bladder cancer	0.000435	0.000488	CcSEcCtD
Tizanidine—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000432	0.000484	CcSEcCtD
Tizanidine—Nausea—Cisplatin—urinary bladder cancer	0.00043	0.000481	CcSEcCtD
Tizanidine—Vision blurred—Epirubicin—urinary bladder cancer	0.000429	0.00048	CcSEcCtD
Tizanidine—Alopecia—Doxorubicin—urinary bladder cancer	0.000427	0.000479	CcSEcCtD
Tizanidine—Mental disorder—Doxorubicin—urinary bladder cancer	0.000424	0.000475	CcSEcCtD
Tizanidine—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000422	0.000473	CcSEcCtD
Tizanidine—Convulsion—Methotrexate—urinary bladder cancer	0.000421	0.000472	CcSEcCtD
Tizanidine—Vomiting—Etoposide—urinary bladder cancer	0.000421	0.000472	CcSEcCtD
Tizanidine—Anaemia—Epirubicin—urinary bladder cancer	0.000421	0.000471	CcSEcCtD
Tizanidine—Agitation—Epirubicin—urinary bladder cancer	0.000418	0.000468	CcSEcCtD
Tizanidine—Rash—Etoposide—urinary bladder cancer	0.000418	0.000468	CcSEcCtD
Tizanidine—Dermatitis—Etoposide—urinary bladder cancer	0.000417	0.000468	CcSEcCtD
Tizanidine—Flatulence—Doxorubicin—urinary bladder cancer	0.000415	0.000465	CcSEcCtD
Tizanidine—Arthralgia—Methotrexate—urinary bladder cancer	0.000414	0.000464	CcSEcCtD
Tizanidine—Tension—Doxorubicin—urinary bladder cancer	0.000413	0.000463	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000411	0.000461	CcSEcCtD
Tizanidine—Malaise—Epirubicin—urinary bladder cancer	0.00041	0.00046	CcSEcCtD
Tizanidine—Discomfort—Methotrexate—urinary bladder cancer	0.000409	0.000458	CcSEcCtD
Tizanidine—Nervousness—Doxorubicin—urinary bladder cancer	0.000409	0.000458	CcSEcCtD
Tizanidine—Vertigo—Epirubicin—urinary bladder cancer	0.000409	0.000458	CcSEcCtD
Tizanidine—Syncope—Epirubicin—urinary bladder cancer	0.000408	0.000457	CcSEcCtD
Tizanidine—Leukopenia—Epirubicin—urinary bladder cancer	0.000407	0.000456	CcSEcCtD
Tizanidine—Back pain—Doxorubicin—urinary bladder cancer	0.000407	0.000456	CcSEcCtD
Tizanidine—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000405	0.000453	CcSEcCtD
Tizanidine—Confusional state—Methotrexate—urinary bladder cancer	0.0004	0.000448	CcSEcCtD
Tizanidine—Loss of consciousness—Epirubicin—urinary bladder cancer	0.0004	0.000448	CcSEcCtD
Tizanidine—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000397	0.000445	CcSEcCtD
Tizanidine—Vision blurred—Doxorubicin—urinary bladder cancer	0.000397	0.000444	CcSEcCtD
Tizanidine—Convulsion—Epirubicin—urinary bladder cancer	0.000394	0.000442	CcSEcCtD
Tizanidine—Infection—Methotrexate—urinary bladder cancer	0.000394	0.000442	CcSEcCtD
Tizanidine—Nausea—Etoposide—urinary bladder cancer	0.000393	0.000441	CcSEcCtD
Tizanidine—Hypertension—Epirubicin—urinary bladder cancer	0.000393	0.00044	CcSEcCtD
Tizanidine—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000391	0.000438	CcSEcCtD
Tizanidine—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000389	0.000436	CcSEcCtD
Tizanidine—Anaemia—Doxorubicin—urinary bladder cancer	0.000389	0.000436	CcSEcCtD
Tizanidine—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000389	0.000435	CcSEcCtD
Tizanidine—Arthralgia—Epirubicin—urinary bladder cancer	0.000387	0.000434	CcSEcCtD
Tizanidine—Agitation—Doxorubicin—urinary bladder cancer	0.000387	0.000433	CcSEcCtD
Tizanidine—Anxiety—Epirubicin—urinary bladder cancer	0.000386	0.000432	CcSEcCtD
Tizanidine—Skin disorder—Methotrexate—urinary bladder cancer	0.000385	0.000432	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000385	0.000431	CcSEcCtD
Tizanidine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000384	0.00043	CcSEcCtD
Tizanidine—Discomfort—Epirubicin—urinary bladder cancer	0.000383	0.000429	CcSEcCtD
Tizanidine—Malaise—Doxorubicin—urinary bladder cancer	0.00038	0.000425	CcSEcCtD
Tizanidine—Dry mouth—Epirubicin—urinary bladder cancer	0.000379	0.000424	CcSEcCtD
Tizanidine—Vertigo—Doxorubicin—urinary bladder cancer	0.000378	0.000424	CcSEcCtD
Tizanidine—Syncope—Doxorubicin—urinary bladder cancer	0.000378	0.000423	CcSEcCtD
Tizanidine—Leukopenia—Doxorubicin—urinary bladder cancer	0.000377	0.000422	CcSEcCtD
Tizanidine—Confusional state—Epirubicin—urinary bladder cancer	0.000374	0.000419	CcSEcCtD
Tizanidine—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000371	0.000416	CcSEcCtD
Tizanidine—Oedema—Epirubicin—urinary bladder cancer	0.000371	0.000416	CcSEcCtD
Tizanidine—Hypotension—Methotrexate—urinary bladder cancer	0.000371	0.000415	CcSEcCtD
Tizanidine—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.00037	0.000415	CcSEcCtD
Tizanidine—Infection—Epirubicin—urinary bladder cancer	0.000369	0.000413	CcSEcCtD
Tizanidine—Shock—Epirubicin—urinary bladder cancer	0.000365	0.000409	CcSEcCtD
Tizanidine—Convulsion—Doxorubicin—urinary bladder cancer	0.000365	0.000409	CcSEcCtD
Tizanidine—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000364	0.000408	CcSEcCtD
Tizanidine—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000364	0.000407	CcSEcCtD
Tizanidine—Hypertension—Doxorubicin—urinary bladder cancer	0.000363	0.000407	CcSEcCtD
Tizanidine—Tachycardia—Epirubicin—urinary bladder cancer	0.000362	0.000406	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000362	0.000405	CcSEcCtD
Tizanidine—Skin disorder—Epirubicin—urinary bladder cancer	0.000361	0.000404	CcSEcCtD
Tizanidine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000359	0.000402	CcSEcCtD
Tizanidine—Arthralgia—Doxorubicin—urinary bladder cancer	0.000358	0.000402	CcSEcCtD
Tizanidine—Anxiety—Doxorubicin—urinary bladder cancer	0.000357	0.0004	CcSEcCtD
Tizanidine—Paraesthesia—Methotrexate—urinary bladder cancer	0.000356	0.000399	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000356	0.000399	CcSEcCtD
Tizanidine—Discomfort—Doxorubicin—urinary bladder cancer	0.000354	0.000397	CcSEcCtD
Tizanidine—Dyspnoea—Methotrexate—urinary bladder cancer	0.000354	0.000396	CcSEcCtD
Tizanidine—Somnolence—Methotrexate—urinary bladder cancer	0.000353	0.000395	CcSEcCtD
Tizanidine—Dry mouth—Doxorubicin—urinary bladder cancer	0.000351	0.000393	CcSEcCtD
Tizanidine—Dyspepsia—Methotrexate—urinary bladder cancer	0.000349	0.000391	CcSEcCtD
Tizanidine—Hypotension—Epirubicin—urinary bladder cancer	0.000347	0.000389	CcSEcCtD
Tizanidine—Confusional state—Doxorubicin—urinary bladder cancer	0.000346	0.000388	CcSEcCtD
Tizanidine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000344	0.000385	CcSEcCtD
Tizanidine—Oedema—Doxorubicin—urinary bladder cancer	0.000344	0.000385	CcSEcCtD
Tizanidine—Fatigue—Methotrexate—urinary bladder cancer	0.000342	0.000383	CcSEcCtD
Tizanidine—Infection—Doxorubicin—urinary bladder cancer	0.000341	0.000382	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000338	0.000379	CcSEcCtD
Tizanidine—Shock—Doxorubicin—urinary bladder cancer	0.000338	0.000379	CcSEcCtD
Tizanidine—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000337	0.000377	CcSEcCtD
Tizanidine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000336	0.000377	CcSEcCtD
Tizanidine—Tachycardia—Doxorubicin—urinary bladder cancer	0.000335	0.000376	CcSEcCtD
Tizanidine—Skin disorder—Doxorubicin—urinary bladder cancer	0.000334	0.000374	CcSEcCtD
Tizanidine—Paraesthesia—Epirubicin—urinary bladder cancer	0.000333	0.000374	CcSEcCtD
Tizanidine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000332	0.000372	CcSEcCtD
Tizanidine—Dyspnoea—Epirubicin—urinary bladder cancer	0.000331	0.000371	CcSEcCtD
Tizanidine—Somnolence—Epirubicin—urinary bladder cancer	0.00033	0.00037	CcSEcCtD
Tizanidine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000327	0.000366	CcSEcCtD
Tizanidine—Dyspepsia—Epirubicin—urinary bladder cancer	0.000327	0.000366	CcSEcCtD
Tizanidine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000324	0.000364	CcSEcCtD
Tizanidine—Hypotension—Doxorubicin—urinary bladder cancer	0.000321	0.00036	CcSEcCtD
Tizanidine—Fatigue—Epirubicin—urinary bladder cancer	0.00032	0.000359	CcSEcCtD
Tizanidine—Constipation—Epirubicin—urinary bladder cancer	0.000318	0.000356	CcSEcCtD
Tizanidine—Urticaria—Methotrexate—urinary bladder cancer	0.000315	0.000353	CcSEcCtD
Tizanidine—Body temperature increased—Methotrexate—urinary bladder cancer	0.000314	0.000351	CcSEcCtD
Tizanidine—Abdominal pain—Methotrexate—urinary bladder cancer	0.000314	0.000351	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000313	0.000351	CcSEcCtD
Tizanidine—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000309	0.000346	CcSEcCtD
Tizanidine—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000306	0.000343	CcSEcCtD
Tizanidine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000306	0.000343	CcSEcCtD
Tizanidine—Somnolence—Doxorubicin—urinary bladder cancer	0.000305	0.000342	CcSEcCtD
Tizanidine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000304	0.00034	CcSEcCtD
Tizanidine—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000302	0.000339	CcSEcCtD
Tizanidine—Fatigue—Doxorubicin—urinary bladder cancer	0.000296	0.000332	CcSEcCtD
Tizanidine—Urticaria—Epirubicin—urinary bladder cancer	0.000295	0.00033	CcSEcCtD
Tizanidine—Constipation—Doxorubicin—urinary bladder cancer	0.000294	0.000329	CcSEcCtD
Tizanidine—Body temperature increased—Epirubicin—urinary bladder cancer	0.000294	0.000329	CcSEcCtD
Tizanidine—Abdominal pain—Epirubicin—urinary bladder cancer	0.000294	0.000329	CcSEcCtD
Tizanidine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000292	0.000328	CcSEcCtD
Tizanidine—Asthenia—Methotrexate—urinary bladder cancer	0.000285	0.000319	CcSEcCtD
Tizanidine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000283	0.000317	CcSEcCtD
Tizanidine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000281	0.000315	CcSEcCtD
Tizanidine—Pruritus—Methotrexate—urinary bladder cancer	0.000281	0.000315	CcSEcCtD
Tizanidine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000274	0.000306	CcSEcCtD
Tizanidine—Urticaria—Doxorubicin—urinary bladder cancer	0.000273	0.000306	CcSEcCtD
Tizanidine—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000272	0.000304	CcSEcCtD
Tizanidine—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000272	0.000304	CcSEcCtD
Tizanidine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000271	0.000304	CcSEcCtD
Tizanidine—Asthenia—Epirubicin—urinary bladder cancer	0.000266	0.000298	CcSEcCtD
Tizanidine—Pruritus—Epirubicin—urinary bladder cancer	0.000263	0.000294	CcSEcCtD
Tizanidine—Dizziness—Methotrexate—urinary bladder cancer	0.000262	0.000294	CcSEcCtD
Tizanidine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000254	0.000285	CcSEcCtD
Tizanidine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000253	0.000284	CcSEcCtD
Tizanidine—Vomiting—Methotrexate—urinary bladder cancer	0.000252	0.000283	CcSEcCtD
Tizanidine—Rash—Methotrexate—urinary bladder cancer	0.00025	0.00028	CcSEcCtD
Tizanidine—Dermatitis—Methotrexate—urinary bladder cancer	0.00025	0.00028	CcSEcCtD
Tizanidine—Asthenia—Doxorubicin—urinary bladder cancer	0.000247	0.000276	CcSEcCtD
Tizanidine—Dizziness—Epirubicin—urinary bladder cancer	0.000246	0.000275	CcSEcCtD
Tizanidine—Pruritus—Doxorubicin—urinary bladder cancer	0.000243	0.000272	CcSEcCtD
Tizanidine—Vomiting—Epirubicin—urinary bladder cancer	0.000236	0.000265	CcSEcCtD
Tizanidine—Nausea—Methotrexate—urinary bladder cancer	0.000236	0.000264	CcSEcCtD
Tizanidine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000235	0.000263	CcSEcCtD
Tizanidine—Rash—Epirubicin—urinary bladder cancer	0.000234	0.000262	CcSEcCtD
Tizanidine—Dermatitis—Epirubicin—urinary bladder cancer	0.000234	0.000262	CcSEcCtD
Tizanidine—Dizziness—Doxorubicin—urinary bladder cancer	0.000227	0.000255	CcSEcCtD
Tizanidine—Nausea—Epirubicin—urinary bladder cancer	0.000221	0.000247	CcSEcCtD
Tizanidine—Vomiting—Doxorubicin—urinary bladder cancer	0.000218	0.000245	CcSEcCtD
Tizanidine—Rash—Doxorubicin—urinary bladder cancer	0.000217	0.000243	CcSEcCtD
Tizanidine—Dermatitis—Doxorubicin—urinary bladder cancer	0.000216	0.000242	CcSEcCtD
Tizanidine—Nausea—Doxorubicin—urinary bladder cancer	0.000204	0.000229	CcSEcCtD
